Literature DB >> 16336388

Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease.

Marissa Daniels1, Gavin M Wright.   

Abstract

BACKGROUND: Non-small-cell lung cancer is a leading cause of cancer morbidity and mortality in Australia. Brain metastases are common, and rapidly fatal if untreated. Optimal management consists of resection and whole brain irradiation. However, there is a paucity of local data documenting survival after such treatment.
METHODS: Medical records for all patients who underwent complete resection of non-small-cell lung cancer at one institution between January 1999 and December 2003 were reviewed in order to determine survival after initial surgery. The survival of all patients was compared with patients who underwent resection of synchronous or metachronous brain metastases and whole brain irradiation as part of their lung cancer management.
RESULTS: Between 1 January 1999 and 31 December 2003, 170 patients underwent complete resection of non-small-cell lung cancer by a thoracic surgeon. Resection of synchronous or metachronous brain metastases followed by whole brain irradiation was also carried out on 15 of these patients. Complete cerebral resection was achieved in 12 cases. The overall 5-year survival after attempted curative resection of brain metastases and successful complete resection was 60% and 70%, respectively. The survival of patients with both cerebral metastasectomy and lung cancer resection approximated that of the cohort of patients that only required complete resection of their lung cancer.
CONCLUSIONS: Control of local disease at each site and long-term survival after lung resection and resection of either synchronous or metachronous brain METASTASIS and whole brain irradiation is readily achievable. We believe this should continue as the standard of care for this presentation.

Entities:  

Mesh:

Year:  2005        PMID: 16336388     DOI: 10.1111/j.1445-2197.2005.03585.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

Review 1.  The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.

Authors:  Elizabeth A David; James M Clark; David T Cooke; Joy Melnikow; Karen Kelly; Robert J Canter
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

Review 2.  The 100 most cited articles on thoracic surgery management of lung cancer.

Authors:  Ke Jin; Quanteng Hu; Jianfeng Xu; Chunlei Wu; Michael K Hsin; Carmelina C Zirafa; Nuria M Novoa; Stefano Bongiolatti; Robert J Cerfolio; Jianfei Shen; Dehua Ma
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

Review 3.  Surgical approach in the oligometastatic patient.

Authors:  Duilio Divisi; Mirko Barone; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  Ann Transl Med       Date:  2018-03

Review 4.  Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature.

Authors:  James C Marsh; Shalini Garg; Julie A Wendt; Benjamin T Gielda; Julius V Turian; Arnold M Herskovic
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

Review 5.  Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review.

Authors:  Luca Bertolaccini; Monica Casiraghi; Giulia Sedda; Filippo de Marinis; Lorenzo Spaggiari
Journal:  Transl Lung Cancer Res       Date:  2021-07

6.  Prognostic value of surgical intervention in advanced lung adenocarcinoma: a population-based study.

Authors:  Shuncang Zhu; Tao Ge; Junjie Hu; Gening Jiang; Peng Zhang
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.